Kisspeptin-10
Also known as: KP-10, KISS-10, Metastin 45-54
4 notable studies · 4 references
TLDR
Kisspeptin-10 is the minimal biologically active kisspeptin fragment and a potent KISS1R agonist with direct human evidence showing stimulation of GnRH-dependent LH, FSH, and testosterone signaling, while its long-term therapeutic role in fertility, hypogonadism, and reproductive medicine remains under investigation.
Research Supports
- Studied for stimulating GnRH-mediated LH and FSH release in humans
- Investigated for effects on testosterone production via the reproductive axis
- Examined for sex differences in reproductive hormone responses
- Studied (as part of the broader kisspeptin family) in fertility and IVF triggering contexts
- Investigated for effects on sexual and emotional brain processing (mainly via kisspeptin-54)
Observations Reported in Research
- George et al., 2011: KP-10 produced potent, dose-dependent LH stimulation and increased LH pulse frequency in men
- 2026 study: daily subcutaneous KP-10 sustained gonadotropin and testosterone increases over 12 days
- Jayasena et al., 2011: hormonal responses to KP-10 showed sexual dimorphism
- Sexual-brain-processing and penile tumescence findings used kisspeptin-54, not KP-10 specifically
- A 2025 study found kisspeptin stimulated reproductive hormones without significantly altering anxiety
These are brief summaries of what the referenced research examined or reported — not conclusions about safety or effectiveness, and not medical advice. See Notable Studies and Sources & References below for the full context and citations.
At a Glance
Classification: Endogenous kisspeptin fragment; KISS1R/GPR54 agonist; reproductive neuroendocrine peptide
Kisspeptin-10 is the 10-amino-acid C-terminal fragment of kisspeptin that retains full biological activity at the kisspeptin receptor. Its central pathway is unusually clean: Kisspeptin → KISS1R → GnRH → LH/FSH → gonadal hormones Kisspeptin signaling is one of the master upstream regulators of human reproductive function. Research has examined Kisspeptin-10 and related kisspeptins in: • GnRH secretion • LH and FSH release • Testosterone • Ovulation • Fertility • IVF • Hypogonadism • Puberty • Sexual behavior • Reproductive brain processing Human evidence is substantial enough that this is not merely an animal fertility peptide. In healthy men, Kisspeptin-10 produces a potent increase in LH and increases LH pulse frequency. And very recent 2026 work found that repeated subcutaneous Kisspeptin-10 could sustain gonadotropin and testosterone stimulation over 12 days, adding important information about repeated exposure.
What Is Kisspeptin-10?
The KISS1 gene produces precursor peptides that are processed into several biologically active kisspeptins. These include: • Kisspeptin-54 • Kisspeptin-14 • Kisspeptin-13 • Kisspeptin-10 They share the biologically important C-terminal sequence. Kisspeptin-10 is essentially the minimal sequence retaining full intrinsic kisspeptin activity. Its receptor is: KISS1R, formerly called GPR54. Discovery of humans with KISS1R mutations causing failure of normal puberty was a major clue that kisspeptin signaling sits near the top of the reproductive endocrine hierarchy.
What Are Researchers Studying?
GnRH and gonadotropin regulation
This is Kisspeptin-10's central research area. Kisspeptin activates KISS1R on reproductive neuroendocrine pathways, stimulating GnRH. GnRH then stimulates the pituitary to release: LH and FSH. In healthy men, intravenous Kisspeptin-10 produced dose-dependent LH responses and increased LH pulse frequency, providing direct human evidence that kisspeptin can stimulate the reproductive axis.
Testosterone
Because LH stimulates Leydig cells in the testes, Kisspeptin-10 can indirectly influence testosterone production. This distinction matters: Kisspeptin does not simply function as an exogenous testosterone analogue. Instead: Kisspeptin → endogenous reproductive signaling → LH → testosterone production. Recent human research found that repeated Kisspeptin-10 exposure could sustain increases in gonadotropins and testosterone over a 12-day protocol. That is especially interesting because chronic stimulation of neuroendocrine receptors can sometimes produce tachyphylaxis or desensitization.
Sex differences in reproductive signaling
Responses to Kisspeptin-10 are not identical in men and women. Human experiments have demonstrated sexual dimorphism in reproductive hormone responses to Kisspeptin-10. In women, response can also vary according to menstrual-cycle phase and underlying reproductive physiology. Therefore, results from healthy male studies cannot simply be generalized to women.
Fertility and assisted reproduction
Kisspeptin biology has become particularly interesting in fertility medicine. Related kisspeptin compounds—especially kisspeptin-54—have been studied as triggers for oocyte maturation during IVF. This matters because conventional hCG-based triggering can contribute to ovarian hyperstimulation syndrome (OHSS) in susceptible patients. Kisspeptin-induced activation of the body's endogenous reproductive axis has therefore been investigated as an alternative strategy. However, this evidence should not automatically be assigned specifically to Kisspeptin-10. That's an important Aminodex distinction: Kisspeptin-family evidence ≠ Kisspeptin-10-specific evidence.
Sexual desire and brain processing
Kisspeptin's role extends beyond hormone secretion. Human neuroimaging research shows that kisspeptin can alter activity in brain regions involved in: • Sexual processing • Attraction • Reward • Emotion • Pair bonding A randomized human study demonstrated modulation of sexual and emotional brain processing. A later randomized clinical trial in men with hypoactive sexual desire disorder found increased activity in sexual-processing brain networks and increased penile tumescence in response to sexual stimuli. But there is a critical compound-specific caveat: Those prominent sexual-brain studies used kisspeptin-54, not Kisspeptin-10. They establish important kisspeptin-system biology, but shouldn't be misrepresented as direct KP-10 trials. That's exactly the sort of distinction Aminodex should make.
Mood and anxiety
Because kisspeptin influences limbic brain systems, researchers have investigated possible effects on mood and anxiety. A 2025 human study found that kisspeptin stimulated reproductive hormones but did not significantly alter anxiety under the studied conditions. Negative findings like this are worth preserving because they prevent every observed brain-network effect from being turned into a therapeutic claim.
How Does It Work?
Kisspeptin-10 binds: KISS1R / GPR54 which is a G-protein-coupled receptor. The core pathway is: Kisspeptin-10 ↓ KISS1R ↓ GnRH neurons ↓ GnRH release ↓ Pituitary ↓ LH + FSH ↓ Gonads ↓ Sex-steroid production + reproductive function This makes kisspeptin fundamentally different from directly supplying a sex hormone. It's acting upstream, helping activate the endogenous reproductive axis.
What Does the Research Show?
Human research
This is relatively strong for a research-market peptide. Human experiments have directly demonstrated: • LH stimulation • Increased LH pulse frequency • FSH changes • Testosterone changes • Sex-dependent hormonal responses • Reproductive neuroendocrine activity The 2011 male study is particularly useful because it specifically investigated Kisspeptin-10, not another kisspeptin form. And the new 2026 study substantially improves the evidence surrounding repeated exposure by showing sustained reproductive-hormone stimulation across 12 days under one administration schedule.
Animal research
Animal research was foundational to discovering kisspeptin's role in: • Puberty • GnRH neurons • Ovulation • Fertility • Reproductive behavior • Energy/reproduction interactions Genetic experiments have been particularly important. Disrupting kisspeptin signaling can profoundly impair reproductive maturation and fertility.
In-vitro research
Cellular research has established: • KISS1R activation • Intracellular signaling • Receptor pharmacology • Structure-activity relationships • Differences among kisspeptin fragments This work helped establish that the short C-terminal Kisspeptin-10 sequence retains potent receptor activity.
Notable Studies
Kisspeptin-10 Is a Potent Stimulator of LH and Increases Pulse Frequency in Men
humanHealthy men received intravenous Kisspeptin-10 across several doses. KP-10 produced potent, dose-dependent stimulation of LH and increased LH pulse frequency, providing direct evidence that Kisspeptin-10 stimulates GnRH-mediated reproductive signaling in humans.
Limitations: Small experimental study in healthy men with acute administration. It did not establish long-term fertility or therapeutic outcomes.
View publication →The Effects of Kisspeptin-10 on Reproductive Hormone Release Show Sexual Dimorphism in Humans
animalResearchers compared reproductive hormonal responses to Kisspeptin-10 and demonstrated substantial differences according to sex and reproductive state.
Limitations: Short-term endocrine responses do not establish fertility treatment efficacy or long-term clinical outcomes.
View publication →Chronic Subcutaneous Kisspeptin-10 Stimulates Gonadotropin Secretion for 12 Days in Healthy Men
animalResearchers investigated whether repeated Kisspeptin-10 stimulation would continue activating the reproductive axis or produce rapid loss of responsiveness. Daily 8-hour subcutaneous infusions maintained increased gonadotropin secretion across 12 days, and gonadotropin responses to subsequent Kisspeptin-10 remained detectable, indicating continued receptor responsiveness under the studied regimen. Testosterone also increased.
Limitations: Healthy male volunteers, short duration, physiological/hormonal endpoints rather than fertility or other long-term clinical outcomes.
View publication →Kisspeptin Modulates Sexual and Emotional Brain Processing in Humans
animalResearchers demonstrated that kisspeptin altered limbic brain responses to sexual and emotional stimuli, connecting reproductive endocrine signaling with human sexual and emotional brain processing.
Limitations: This study used kisspeptin-54 rather than Kisspeptin-10, so it provides family-level mechanistic context rather than direct KP-10 evidence.
View publication →What We Still Don't Know
• Optimal long-term administration patterns • Long-term safety • Degree of tachyphylaxis under different exposure patterns • Effects on fertility outcomes after prolonged administration • Which reproductive disorders respond best • Comparative effectiveness versus established fertility treatments • Long-term effects in men with hypogonadism • Whether testosterone increases translate into meaningful clinical outcomes • Whether sexual-behavior findings from KP-54 translate directly to KP-10 • Effects across menstrual-cycle phases • Effects in postmenopausal populations • Interaction with metabolic disease • Whether research-market products accurately contain the peptide and purity stated
Related Compounds
Recent publications
Latest titles from PubMed, not reviewed by Aminodex. Not an endorsement. See all on PubMed ↗
Take the Kisspeptin-10 research with you.
Get the Aminodex Kisspeptin-10 Brief—a concise summary of the research, notable studies, evidence types, limitations, and references.
One-time email. We do not add you to any mailing list.
Sources & References
- George JT, Veldhuis JD, Roseweir AK, et al. Kisspeptin-10 Is a Potent Stimulator of LH and Increases Pulse Frequency in Men. Journal of Clinical Endocrinology & Metabolism. 2011.
- Jayasena CN, Nijher GMK, Comninos AN, et al. The Effects of Kisspeptin-10 on Reproductive Hormone Release Show Sexual Dimorphism in Humans. Journal of Clinical Endocrinology & Metabolism. 2011.
- Chronic Subcutaneous Kisspeptin-10 Stimulates Gonadotropin Secretion for 12 Days in Healthy Men. 2026.
- Comninos AN, Wall MB, Demetriou L, et al. Kisspeptin Modulates Sexual and Emotional Brain Processing in Humans. Journal of Clinical Investigation. 2017.
Supplier Listings
Disclosure: The owner of Aminodex operates the supplier(s) marked below. These listings are promotion for businesses we own, not independent recommendations. Read our disclosures.